title: Diabetic foot and renal failure. Theoretical and practical considerations.
authors.forename: Fátima
authors.initials: F
authors.lastname: Batista-García
authors.forename: Michele
authors.initials: M
authors.lastname: Hernández
authors.forename: Santiago
authors.initials: S
authors.lastname: Suria
authors.forename: Noemí
authors.initials: N
authors.lastname: Esparza
authors.forename: M Dolores
authors.initials: MD
authors.lastname: Checa
mesh_terms: D000368:Aged; D002317:Cardiovascular Agents / Q000627:therapeutic use; D015897:Comorbidity; D017719:Diabetic Foot / Q000453:epidemiology* / Q000628:therapy; D003928:Diabetic Nephropathies / Q000453:epidemiology* / Q000517:prevention & control; D019468:Disease Management; D050171:Dyslipidemias / Q000453:epidemiology; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D019983:Guideline Adherence; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012189:Retrospective Studies; D055502:Secondary Prevention; D012907:Smoking / Q000453:epidemiology
chemical_list: D002317:Cardiovascular Agents; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin